Inspired by the difference healthy skin can make
To us, innovation means relentlessly pursuing new and better ways to treat skin conditions. We do this through scientific study and research, collaboration with healthcare providers, doctors and dermatologists and by working with experts in other related fields of science and medicine. Very importantly, we listen to people who experience these skin conditions, to understand how their lives are affected and what they want and need.
As a GSK company, we are privileged to have access to wide research, scientific and investment resources all over the world. By investigating and using the latest knowledge from other therapeutic areas, we can often develop new products more quickly. Sometimes we invest in potential new treatments discovered by others, so we can bring them to market and to the individuals who need them more quickly.
At Stiefel we’re changing that, with our determination to develop more and better science-led solutions that make a real difference and raise expectations of skin health.
Our specialist teams focus on increasing our understanding of skin disease. It’s the starting point for all our innovation. At our Centre for Skin Biology, we investigate skin function, disease pathways, protection, repair and regeneration of the skin. We’re constantly working to find out more about what’s behind the symptoms of skin conditions, compared to healthy skin, so we can find possible new solutions to both common and rare skin conditions.
The Stiefel range includes an integrated portfolio of daily skin care and prescription treatments. We produce topical products (to apply externally), oral treatments (to take by mouth) and injectibles. We’re always striving to improve our existing products, to discover new and innovative treatments and to find ways to address unmet patient needs
We currently specialise in five therapy areas:
- atopic dermatitis (eczema)
- Superficial skin infections (SSIs)
- Non-melanoma skin cancers